Real-world effectiveness and treatment (tx) patterns in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in Japan: Results from the JAVEMACS chart review study.

Detalles Bibliográficos
Publicado en:Journal of Clinical Oncology Vol. 43; pp. 701 - 943
Autores principales: Kitamura, Hiroshi, Kobayashi, Takashi, Kimura, Go, Ikeda, Masaomi, Yonemori, Kan, Kawamura, Norihiko, Fujihara, Atsuko, Abe, Takashige, Shimizu, Fumitaka, Fujimoto, Kiyohide, Nakagawa, Tohru, Hatakeyama, Shingo, Murakami, Kaoru, Nishihara, Kiyoaki, Ikarashi, Daiki, Masumori, Naoya, Kambe, Anzu, Shono, Michihiro, Shirotake, Suguru, Kikuchi, Eiji
Formato: Journal Article
Publicado: American Society of Clinical Oncology 2/10/2025 Supplement5
Acceso en línea:Ver este registro en EBSCOhost